Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues

Journal of Clinical Investigation

Volumn 103, Issue 10, 1999, Pages 1391-1398

  Bucy, R Pat ^a,b   Hockett, Richard D ^a   Derdeyn, Cynthia A ^a   Saag, Michael S ^b   Squires, Kathleen ^b   Sillers, Michael ^c   Mitsuyasu, Ronald T ^d   Kilby, J Michael ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c Kentucky   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LYMPH NODE BIOPSY; LYMPHOCYTE PROLIFERATION; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS INHIBITION;

EID: 0032741277     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5863     Document Type: Article

References (50)

1. Ho, D.D., et al. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:123-126.
2. Wei, X., et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:117-122.
3. Mosier, D., Sprent, J., and Tough, D. 1995. CD4+ cell turnover. Nature. 375:193-194.
4. Dimitrov, D.S. and Martin, MA 1995. HIV results in the frame. CD4+ cell turnover. Nature. 375:194-195.
5. Grossman, Z. and Herberman, R.B. 1997. T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host. Nat. Med. 3:486-490.
6. Pakker, N.G., et al. 1998. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat. Med. 2:208-214.
7. Mohri, H., Bonhoeffer, S., Monard, S., Perelson, A.S., and Ho, D.D. 1998. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science. 279:1223-1227.
8. Hockett, R.D., Janowski, K.M., and Bucy, R.P. 1995. Simultaneous quantitation of multiple cytokine mRNAs by RT-PCR utilizing plate based EIA methodology. J. Immunol. Methods. 187:273-285.
9. Chomczynski, P., and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidmium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
10. Bucy, R.P., Chen, C.H, Cihak, J., Losch, U., and Cooper, M.D. 1988. Avian T cells expressing gamma delta receptors localize in the splenic sinusoid and the intestinal epithelium. J. Immunol. 141:2200-2205.
11. Dustin, M.L. and Springer, T.A. 1991. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu. Rev. Immunol. 9:27-66.
12. Shimizu, Y., et al. 1991. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J. Cell Biol. 113:1203-1212.
13. van Kooyk, Y., van de Wiel-van Kemenade, E., Weder, P., Huijbens, R.J., and Figdor, C.G. 1993. Lymphocyte function-associated antigen 1 dominates very late antigen 4 in binding of activated T cells to endothelium. J. Exp. Med 177:185-190.
14. Oppenheimer-Marks, N., Davis, L.S., Bogue, D.T., Ramberg, J., and Lipsky, P.E. 1991. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J. Immunol. 147:2913-2921.
15. Shimizu, Y., van Seventer, G.A., Horgan, K.J., and Shaw, S. 1990. Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. Immunol Rev. 114:109-143.
16. Nakajima, H., Sano, H., Nishimura, T., Yoshida, S., and Iwamoto, I. 1994. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/Lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Med. 179:1145-1154.
17. Pelletier, R.P., et al. 1992. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. J Immunol. 149:2473-2481.
18. Palmer, L.D., et al. 1997. Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins. J. Exp. Med. 185:1381-1386.
19. Wolthers, K.C., et al. 1996. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science. 274:1543-1547.
20. Harley, C.B., Futcher, A.B., and Greider, C.W. 1990. Telomeres shorten during ageing of human fibroblasts. Nature. 345:458-460.
21. Allsopp, R.C., et al. 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA. 89:10114-10118.
22. Allsopp, R.C., et al. 1995. Telomere shortening is associated with cell division in vitro and in vivo. Exp. Cell Res. 220:194-200.
23. Effros, R.B., et al. 1996. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 10:F17-F22.
24. Sachsenberg, N., et al. 1998. Turnover of CD4(+) and CD8(+) T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J. Exp. Med. 187:1295-1303.
25. Zhang, Z.Q., et al. 1998. Kinetics of CD4+ T cell repopularion of lymphoid tissues after treatment of HIV-1 infection. Proc. Natl. Acad. Sci. USA. 95:1154-1159.
26. Hellerstein, M.K., and McCune, J.M. 1997. T cell turnover in HIV-1 disease. Immunity. 7:583-589.
27. Macallan, D.C., et al, 1998. Measurement of cell proliferation by labeling of DMA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. Proc. Natl. Acad. Sci. USA. 95:708-713.
28. Waterhouse, P., et al. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:985-988.
29. Karandikar, N.J., Vanderlugt, C.L. Walunas, T.L., Miller, S.D., and Blue-stone, J.A. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783-788.
30. Sprent, J., and Webb, S.R. 1987. Function and specificity of T cell subsets in the mouse. Adv. Immunol. 41:39-133.
31. Sprent, J., Schaefer, M., Hurd, M., Surh, C.D., and Ron, Y. 1991. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J. Exp. Med. 174:717-728.
32. Tough, D.F., and Sprent, J. 1994. Turnover of naive and memory phenotype T cells. J. Exp. Med. 179:1127-1136.
33. Sprent, J. 1993. Life spans of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5:433-438.
34. Ghobrial, R., Boublik, M., Winn, H., and Auchincloss, H. 1989. In vivo use of monoclonal antibodies against murine T cell antigens. Clin. Immunol. Immunopathol. 52:486-506.
35. + T cells by anti-CD4 monoclonal antibody (GK1.5) in young and aged mice. J. Immunol. 154:6644-6654.
36. Mackall, C.L., et al. 1995. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 332:143-149.
37. Mackall, C.L., et al. 1997. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood, 89:3700-3707.
38. Moreland, L.W., et al. 1994. Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody: Long term followup of CD4+ T cell counts. Arthritis Rheum. 37:834-838.
39. Moreland, L.W., Bucy, R.P., and Koopman, W.J. 1995. Regeneration of T cells after chemotherapy. N. Engl. J. Med. 332:1651-1652.
40. Wong, J.K., et al. 1997, Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 278:1291-1295.
41. Finzi, D., et al. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 278:1295-1300.
42. Butcher, B.C., and Picker, L.J. 1996. Lymphocyte homing and homeostasis. Science. 272:60-66.
43. Malone, J.L., et al. 1992. Abnormalities of morning serum cortisol levels and circadian rhythms of CD4+ lymphocyte counts in human immunodeficiency virus type 1-infected adult patients. J Infect. Dis. 165:185-186.
44. Malone, J.L., et al. 1990. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J. Acequir. Immune Defic. Syndr. 3:144-151.
45. Kelleher, A.D., Carr, A., Zaunders, J., and Cooper, D.A. 1996. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J. Infect. Dis. 173:321-329.
46. Lederman, M.M., et al. 1998. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J. Infect. Dis. 178:70-79.
47. Autran, B., et al. 1997. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 277:112-116.
48. Andersson, J., et al. 1998. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS. 12:F123-F129.
49. Hammer, S.M., et al. 1997. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med. 337:725-733.
50. Gulick, R.M., et al. 1997. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337:734-739.